CompleteRx

Five ways health executives can impact the opioid crisisConsider these five opportunities to help curb one of the biggest public health issues of the year.
Two opioid use disorder drug developments to watchNew physician-administered therapies on the horizon may help rein in the opioid epidemic.
Brace for a barrage of biosimilarsThe next few years will see the healthcare industry bracing itself for new biosimilar products for a range of illnesses from oncology to rheumatoid arthritis.
Omnicell and CompleteRx Join Forces
Omnicell and CompleteRx Join ForcesTwo groups join up to help the Massachusetts State Office of Pharmacy Services.
Partnership aims to make insulin more affordableCVS, Novo Nordisk launch a prescription savings program to help patients afford essential medications.
Five pharmacy regulations health execs must keep on their radars in 2017Here are five critical regulations that executives can begin to prepare for today.
Four ways to reduce dangerous medical errors at your hospitalConsider these tactics that analyze and address medical errors at a system level.
Four reasons why a hospital should open an integrated pharmacyWhen is retail right? Consider these four benefits that will impact the bottom line.
Insurer expands hep C drug coverageNationwide class action suit spurs new coverage decision for hepatitis C medications.